Synthon B.V.
Synthon B.V., a leading player in the pharmaceutical industry, is headquartered in the Netherlands (NL) and operates across key regions in Europe and beyond. Founded in 1991, Synthon has established itself as a pioneer in the development and manufacturing of complex generics and innovative medicines, focusing on areas such as oncology and neurology. The company is renowned for its unique approach to drug development, leveraging advanced technologies to create high-quality, cost-effective therapeutic solutions. With a strong commitment to research and development, Synthon has achieved significant milestones, including numerous product launches and partnerships that enhance its market position. As a trusted name in the pharmaceutical sector, Synthon B.V. continues to drive innovation and improve patient outcomes globally.
DitchCarbon Score
How does Synthon B.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Synthon B.V.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Synthon B.V.'s reported carbon emissions
Synthon B.V., headquartered in the Netherlands (NL), currently does not report any specific carbon emissions data, as indicated by the absence of figures in the latest emissions report. Additionally, there are no documented reduction targets or climate pledges available for the company. It is important to note that Synthon B.V. is a current subsidiary and may inherit climate-related data and commitments from its parent organisation. However, specific details regarding these cascaded emissions or targets are not provided. As a participant in the pharmaceutical industry, Synthon B.V. operates within a sector increasingly focused on sustainability and carbon reduction. The absence of reported emissions data highlights a potential area for improvement in transparency and accountability regarding climate commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Synthon B.V. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
